Antihypertensive Combination Therapy: Optimizing Blood Pressure Control and Cardiovascular Risk Reduction
Why the study?
Does combination antihypertensive therapy improve blood pressure control and reduce cardiovascular risk compared to monotherapy in hypertensive patients?
Population
Hypertensive patients, particularly those with blood pressure levels >160/100 mm Hg
Comparison
Combination therapy of 2 or more… vs Monotherapy
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports combination therapy for severe hypertension; leaves open optimal regimens and RCT confirmation of CV outcomes.
Structured PICO
Does combination antihypertensive therapy improve blood pressure control and reduce cardiovascular risk compared to monotherapy in hypertensive patients?
P
Population
Hypertensive patients, particularly those with blood pressure levels >160/100 mm Hg
I
Intervention
Combination therapy of 2 or more antihypertensive medications (angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, calcium channel blockers, and diuretics)
C
Comparator
Monotherapy
O
Outcome
Achievement of blood pressure goal and reduction of cardiovascular risk
Combination antihypertensive therapy is often necessary to achieve blood pressure targets and reduce cardiovascular risk, especially in patients with severe hypertension.
Cite This Study
Shawna D. Nesbitt (2007) studied this question.